Viewing Company
Company Name:
Viracta Therapeutics, Inc.
CIK:
1061027
Phone:
None
Fiscal Year End:
None
Entity Type:
SIC:
-
Category Type:
Entity Name:
None
First Filing Date:
2011-08-11
Last Filing Date:
2024-11-13
SEC Filings
| Start | End | Frame | Filed | ACCN | Value | View |
|---|---|---|---|---|---|---|
| 2013-01-01 | 2013-03-31 | CY2012Q1 | 2013-05-09 | 0001193125-13-211055 | $ 51,587,000 | View |
| 2014-01-01 | 2014-03-31 | CY2013Q1 | 2014-05-07 | 0001193125-14-187522 | $ 56,313,000 | View |
| 2012-01-01 | 2012-03-31 | CY2012Q1I | 2012-05-15 | 0001193125-12-234607 | $ 46,793,000 | View |
| 2014-04-01 | 2014-06-30 | CY2014Q2I | 2014-08-05 | 0001193125-14-295865 | $ 60,246,000 | View |
| 2014-07-01 | 2014-09-30 | CY2014Q3I | 2014-11-10 | 0001564590-14-005430 | $ 60,549,000 | View |
| 2012-07-01 | 2012-09-30 | CY2012Q3 | 2012-11-08 | 0001193125-12-460459 | $ 47,398,000 | View |
| 2017-04-01 | 2017-06-30 | CY2016Q2 | 2017-07-27 | 0001564590-17-014266 | $ 21,521,000 | View |
| 2017-07-01 | 2017-09-30 | CY2016Q3 | 2017-11-02 | 0001564590-17-021235 | $ 23,678,000 | View |
| 2013-07-01 | 2013-09-30 | CY2013Q3I | 2013-11-12 | 0001193125-13-438287 | $ 51,698,000 | View |
| 2015-01-01 | 2015-03-31 | CY2014Q1 | 2015-05-05 | 0001564590-15-003315 | $ 67,641,000 | View |
| 2015-07-01 | 2015-09-30 | CY2014Q3 | 2015-11-05 | 0001564590-15-009661 | $ 74,776,000 | View |
| 2016-01-01 | 2016-03-31 | CY2015Q1 | 2016-05-09 | 0001564590-16-018570 | $ 86,660,000 | View |
| 2016-07-01 | 2016-09-30 | CY2015Q3 | 2016-11-03 | 0001564590-16-027314 | $ 14,503,000 | View |
| 2017-01-01 | 2017-03-31 | CY2016Q1 | 2017-05-08 | 0001564590-17-009369 | $ 21,029,000 | View |
| 2018-01-01 | 2018-03-31 | CY2017Q1 | 2018-05-08 | 0001564590-18-011879 | $ 34,345,000 | View |
| 2018-04-01 | 2018-06-30 | CY2017Q2 | 2018-08-08 | 0001564590-18-020104 | $ 34,417,000 | View |
| 2018-07-01 | 2018-09-30 | CY2017Q3 | 2018-11-05 | 0001564590-18-026884 | $ 36,095,000 | View |
| 2018-01-01 | 2018-12-31 | CY2017 | 2019-03-07 | 0001564590-19-006828 | $ 35,582,000 | View |
| 2019-01-01 | 2019-03-31 | CY2018Q1 | 2019-05-08 | 0001564590-19-017293 | $ 59,142,000 | View |
| 2019-04-01 | 2019-06-30 | CY2018Q2 | 2019-08-07 | 0001564590-19-030130 | $ 72,190,000 | View |
| 2019-07-01 | 2019-09-30 | CY2018Q3 | 2019-11-12 | 0001564590-19-042985 | $ 105,070,000 | View |
| 2019-01-01 | 2019-12-31 | CY2018 | 2020-03-10 | 0001564590-20-009783 | $ 87,129,000 | View |
| 2020-01-01 | 2020-03-31 | CY2019Q1 | 2020-05-07 | 0001564590-20-022937 | $ 111,393,000 | View |
| 2020-04-01 | 2020-06-30 | CY2019Q2 | 2020-08-11 | 0001564590-20-039326 | $ 111,416,000 | View |
| 2020-07-01 | 2020-09-30 | CY2019Q3 | 2020-11-16 | 0001564590-20-054194 | $ 15,929,000 | View |
| 2020-01-01 | 2020-12-31 | CY2020Q4I | 2021-02-24 | 0001564590-21-007784 | $ 14,093,000 | View |
| 2020-01-01 | 2020-12-31 | CY2019 | 2021-03-23 | 0001193125-21-091167 | $ 2,901,990 | View |
| 2021-01-01 | 2021-03-31 | CY2020Q1 | 2021-05-13 | 0001193125-21-159809 | $ 15,166,737 | View |
| 2021-04-01 | 2021-06-30 | CY2021Q2 | 2021-08-12 | 0000950170-21-001376 | $ 37,221,407 | View |
| 2021-07-01 | 2021-09-30 | CY2021Q3 | 2021-11-10 | 0000950170-21-004118 | $ 37,353,418 | View |
| 2012-04-01 | 2012-06-30 | CY2012Q2I | 2012-08-09 | 0001193125-12-347564 | $ 46,953,000 | View |
| 2012-10-01 | 2012-12-31 | CY2011Q4 | 2013-03-13 | 0001193125-13-105232 | $ 51,412,000 | View |
| 2013-04-01 | 2013-06-30 | CY2013Q2I | 2013-08-02 | 0001193125-13-317328 | $ 51,630,000 | View |
| 2013-10-01 | 2013-12-31 | CY2012Q4 | 2014-03-06 | 0001193125-14-086649 | $ 54,060,000 | View |
| 2014-10-01 | 2014-12-31 | CY2013Q4 | 2015-03-12 | 0001564590-15-001589 | $ 63,041,000 | View |
| 2015-04-01 | 2015-06-30 | CY2014Q2 | 2015-07-30 | 0001564590-15-005869 | $ 72,513,000 | View |
| 2015-10-01 | 2015-12-31 | CY2014Q4 | 2016-03-14 | 0001564590-16-014612 | $ 76,683,000 | View |
| 2016-04-01 | 2016-06-30 | CY2016Q2I | 2016-07-29 | 0001564590-16-021786 | $ 86,960,000 | View |
| 2016-10-01 | 2016-12-31 | CY2015Q4 | 2017-03-09 | 0001564590-17-003862 | $ 19,285,000 | View |
| 2017-10-01 | 2017-12-31 | CY2017Q4 | 2018-03-09 | 0001564590-18-005146 | $ 31,667,000 | View |
| 2010-01-01 | 2011-12-31 | CY2011Q4I | 2012-03-14 | 0001193125-12-114990 | $ 46,412,000 | View |
| 2022-01-01 | 2022-03-31 | CY2022Q1I | 2022-05-10 | 0000950170-22-009031 | $ 0 | View |
| 2021-01-01 | 2021-12-31 | CY2020Q4I | 2022-03-17 | 0000950170-22-003991 | $ 3 | View |
| 2022-04-01 | 2022-06-30 | CY2022Q2I | 2022-08-09 | 0000950170-22-016042 | $ 1,562,000 | View |
| 2022-07-01 | 2022-09-30 | CY2021Q3 | 2022-11-10 | 0000950170-22-024539 | $ -199,000 | View |
| 2022-01-01 | 2022-12-31 | CY2022 | 2023-03-14 | 0000950170-23-007905 | $ 564 | View |
| 2023-01-01 | 2023-03-31 | CY2023Q1I | 2023-05-09 | 0000950170-23-019739 | $ 567,000 | View |
| 2023-01-01 | 2023-06-30 | CY2023Q2I | 2023-08-14 | 0000950170-23-042483 | $ 1,733,000 | View |
| 2023-01-01 | 2023-09-30 | CY2023Q3I | 2023-11-09 | 0000950170-23-062145 | $ 2,578,000 | View |
| 2023-01-01 | 2021-05-28 | CY2023 | 2024-03-07 | 0000950170-24-027982 | $ 75,000,000 | View |
| 2024-01-01 | 2024-03-31 | CY2024Q1 | 2024-05-09 | 0000950170-24-057250 | $ 1,000 | View |
| 2024-01-01 | 2024-06-30 | CY2024Q2I | 2024-08-14 | 0000950170-24-096982 | $ 5,000,000 | View |
| 2024-07-01 | 2024-09-30 | CY2024Q3 | 2024-11-13 | 0000950170-24-126385 | $ 25,000 | View |
| 2011-01-01 | 2011-06-30 | CY2011Q2I | 2011-08-11 | 0001193125-11-219590 | $ 40,294,000 | View |
| 2011-01-01 | 2011-09-30 | CY2011Q3I | 2011-11-14 | 0001193125-11-311186 | $ 35,811,000 | View |
SEC Facts By Type
| Type | Name | Description | View |
|---|---|---|---|
| dei | Entity Common Stock, Shares Outstanding | Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument. | View |
| us-gaap | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge. | View |
| us-gaap | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented. | View |
| us-gaap | Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss), Net of Tax (Deprecated 2018-01-31) | The change in unrealized holding gain (loss), net of tax, on available-for-sale securities included in a separate component of shareholders' equity during the period. | View |
| us-gaap | Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) | This element represents the portion of the balance sheet assertion valued at fair value by the entity whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission. This item represents Available-for-sale Securities which consist of all investments in certain debt and equity securities neither classified as trading or held-to-maturity securities. A debt security represents a creditor relationship with an enterprise. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certain preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities which are categorized as Available-for-sale. | View |
| us-gaap | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Losses (Deprecated 2013-01-31) | Amount of the excess of amortized cost basis over fair value of securities that have been in a loss position for less than twelve months for securities categorized neither as held-to-maturity nor trading securities. | View |
| us-gaap | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents | Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash, Cash Equivalents, and Short-term Investments | Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Long-term Debt, Gross | Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. | View |
| us-gaap | Debt Instrument, Convertible, Beneficial Conversion Feature | Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date. | View |
| us-gaap | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset. | View |
| us-gaap | Debt Securities, Available-for-sale, Realized Gain (Loss) | Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Debt Securities, Available-for-sale, Unrealized Gain (Loss) | Amount of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Deferred Tax Liabilities, Gross | Amount of deferred tax liability attributable to taxable temporary differences. | View |
| us-gaap | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. | View |
| us-gaap | Earnings Per Share, Basic and Diluted | The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | Percentage of the difference, between reported income tax expense (benefit) and the expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, that is attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority interest income (expense), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, change in enacted tax rate, prior year income taxes, change in deferred tax asset valuation allowance, and other adjustments. | View |
| us-gaap | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. | View |
| us-gaap | Increase (Decrease) in Employee Related Liabilities | The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year Two | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. | View |
| us-gaap | Other Accrued Liabilities, Noncurrent | Amount of expenses incurred but not yet paid classified as other, due after one year or the normal operating cycle, if longer. | View |
| us-gaap | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale. | View |
| us-gaap | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised. | View |
| us-gaap | Research and Development Expense | The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. | View |
| us-gaap | Severance Costs | Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | Weighted average price of options that were either forfeited or expired. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit | The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. | View |
| us-gaap | Share-based Goods and Nonemployee Services Transaction, Expense (Deprecated 2013-01-31) | The amount of expense reported during the period resulting from the transaction in which equity securities were issued to pay for goods or nonemployee services. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. | View |
| us-gaap | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price | Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding. | View |
| us-gaap | Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit | The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date. | View |
| us-gaap | Stockholders' Equity Attributable to Parent | Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. | View |
| us-gaap | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. | View |
| us-gaap | Debt Securities, Available-for-sale, Unrealized Loss | Amount of unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Payments to Acquire Short-term Investments | The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. | View |
| us-gaap | Repayments of Long-term Lines of Credit | The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer. | View |
| us-gaap | Amortization of Debt Issuance Costs and Discounts | Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Warrant Issued | Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants. | View |
| dei | Entity Public Float | The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter. | View |
| invest | Investment Warrants, Exercise Price | Exercise price of the warrants. | View |
| us-gaap | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accretion Expense | Amount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations. | View |
| us-gaap | Accrued Liabilities, Current | Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accrued Payroll Taxes, Current | Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accrued Professional Fees, Current | Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services. | View |
| us-gaap | Additional Paid in Capital | Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock. | View |
| us-gaap | Additional Paid in Capital, Common Stock | Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt | Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock | Amount of decrease (increase) in additional paid in capital (APIC) for the increase in carrying amount of redeemable preferred stock. | View |
| us-gaap | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. | View |
| us-gaap | Adjustments to Additional Paid in Capital, Stock Split | Amount of decrease in additional paid in capital (APIC) resulting from a stock split in which per-share par value or stated value is not changed proportionately. | View |
| us-gaap | Share-based Payment Arrangement, Expense | Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. | View |
| us-gaap | Assets | Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Current | Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Assets, Fair Value Disclosure | Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. | View |
| us-gaap | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Debt Securities, Available-for-sale, Amortized Cost | Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Available-for-sale Securities | Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading. | View |
| us-gaap | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale. | View |
| us-gaap | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale. | View |
| us-gaap | Available-for-sale Securities, Amortized Cost Basis | This item represents the cost of debt and equity securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any. | View |
| us-gaap | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | Amount of accumulated unrealized loss on investments in debt and equity securities classified as available-for-sale that have been in a continuous loss position for less than twelve months. | View |
| us-gaap | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | This item represents the aggregate fair value of investments in debt and equity securities categorized neither as held-to-maturity nor trading securities that have been in a continuous unrealized loss position for less than twelve months. | View |
| us-gaap | Debt Securities, Available-for-sale | Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Available-for-sale Securities, Gross Realized Gain (Loss) | This item represents the difference between the gross realized gains and losses realized on the sale of debt or equity securities categorized neither as held-to-maturity nor trading securities. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities. | View |
| us-gaap | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) | This item represents the gross unrealized losses for securities, at a point in time, which are categorized neither as held-to-maturity nor trading securities. | View |
| us-gaap | Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) | This item represents the gross unrealized gains for securities, at a point in time, which are categorized neither as held-to-maturity nor trading securities. | View |
| us-gaap | Business Acquisition, Transaction Costs | Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition. | View |
| us-gaap | Business Acquisition, Percentage of Voting Interests Acquired | Percentage of voting equity interests acquired at the acquisition date in the business combination. | View |
| us-gaap | Business Acquisition, Share Price | Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination. | View |
| us-gaap | Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination | Fair value at acquisition-date of the assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interests issued by the acquirer, including but not limited to, instruments or interests issued or issuable in consideration for the business combination. | View |
| us-gaap | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets | Amount of assets acquired at the acquisition date. | View |
| us-gaap | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date. | View |
| us-gaap | Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net | Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed. | View |
| us-gaap | Capital Expenditures Incurred but Not yet Paid | Future cash outflow to pay for purchases of fixed assets that have occurred. | View |
| us-gaap | Cash Acquired from Acquisition | The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business). | View |
| us-gaap | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Cash and Cash Equivalents, Fair Value Disclosure | Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash and Cash Equivalents, Period Increase (Decrease) | Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes. | View |
| us-gaap | Convertible Preferred Stock, Shares Issued upon Conversion | Number of shares issued for each share of convertible preferred stock that is converted. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. | View |
| us-gaap | Cash Equivalents, at Carrying Value | Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. | View |
| us-gaap | Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) | Exercise price per share or per unit of warrants or rights outstanding. | View |
| us-gaap | Class of Warrant or Right, Exercise Price of Warrants or Rights | Exercise price per share or per unit of warrants or rights outstanding. | View |
| us-gaap | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. | View |
| us-gaap | Class of Warrant or Right, Outstanding | Number of warrants or rights outstanding. | View |
| us-gaap | Common Stock, Capital Shares Reserved for Future Issuance | Aggregate number of common shares reserved for future issuance. | View |
| us-gaap | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | View |
| us-gaap | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | View |
| us-gaap | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | View |
| us-gaap | Common Stock, Value, Subscriptions | Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds. | View |
| us-gaap | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. | View |
| us-gaap | Conversion of Stock, Amount Converted | "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Debt Instrument, Unamortized Discount | Amount, after accumulated amortization, of debt discount. | View |
| us-gaap | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset. | View |
| us-gaap | Deferred Rent Credit, Noncurrent | For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date. | View |
| us-gaap | Deferred Revenue, Current | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current. | View |
| us-gaap | Deferred Revenue, Noncurrent | Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent. | View |
| us-gaap | Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) | Amount of previously reported deferred or unearned revenue that was recognized as revenue during the period. Deferred revenue is a liability related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. | View |
| us-gaap | Deferred Revenue, Revenue Recognized | Amount of revenue recognized that was previously reported as deferred or unearned revenue. | View |
| us-gaap | Deferred Tax Assets, Deferred Income | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from deferred income. | View |
| us-gaap | Deferred Tax Assets, Gross | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Deferred Tax Assets, Net | Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. | View |
| us-gaap | Deferred Tax Assets, Net of Valuation Allowance | Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. | View |
| us-gaap | Deferred Tax Assets, Other | Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. | View |
| us-gaap | Deferred Tax Assets, Property, Plant and Equipment | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment. | View |
| us-gaap | Deferred Tax Assets, Tax Credit Carryforwards, Research | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. | View |
| us-gaap | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. | View |
| us-gaap | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. | View |
| us-gaap | Deferred Tax Assets, Valuation Allowance | Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. | View |
| us-gaap | Deferred Tax Expense from Stock Options Exercised | Amount of deferred tax expense from write-off of the deferred tax asset related to deductible stock options at exercise. | View |
| us-gaap | Depreciation, Amortization and Accretion, Net | The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method. | View |
| us-gaap | Depreciation, Depletion and Amortization | The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. | View |
| us-gaap | Derivative Liability, Fair Value, Gross Liability | Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement. | View |
| us-gaap | Derivative Liability, Current | Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. | View |
| us-gaap | Dividend, Share-based Payment Arrangement, Cash | Amount of paid and unpaid cash dividends declared for award under share-based payment arrangement. | View |
| us-gaap | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | View |
| us-gaap | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Percent | Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | Percentage of domestic federal statutory tax rate applicable to pretax income (loss). | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research and development expense. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other tax credits. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit). | View |
| us-gaap | Employee-related Liabilities, Current | Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | Amount of cost not yet recognized for nonvested award under share-based payment arrangement. | View |
| us-gaap | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | Amount of cost to be recognized for option under share-based payment arrangement. | View |
| us-gaap | Fair Value Adjustment of Warrants | Amount of expense (income) related to adjustment to fair value of warrant liability. | View |
| us-gaap | Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) | Expected dividends to be paid to holders of the underlying shares or financial instruments (expressed as a percentage of the share or instrument's price). | View |
| us-gaap | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) | Measure of dispersion, in percentage terms (for instance, the standard deviation or variance), for a given stock price. | View |
| us-gaap | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) | Risk-free interest rate assumption used in valuing an instrument. | View |
| us-gaap | Long-term Federal Home Loan Bank Advances | Including both current and noncurrent portions, Federal Home Loan Bank borrowings initially due beyond one year or beyond the normal operating cycle if longer. | View |
| us-gaap | Financing Interest Expense | This element represents interest incurred for borrowed money which was used to produce goods or render services. | View |
| us-gaap | Gain (Loss) on Disposition of Property Plant Equipment | Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property. | View |
| us-gaap | Gain (Loss) on Extinguishment of Debt | Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. | View |
| us-gaap | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Domestic | The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations. | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | View |
| us-gaap | Income (Loss) from Continuing Operations before Income Taxes, Foreign | The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile. | View |
| us-gaap | Income (Loss) from Continuing Operations, Per Basic and Diluted Share | The amount of net income (loss) from continuing operations per each basic and diluted share of common stock or unit when the per share amount is the same for both basic and diluted shares. | View |
| us-gaap | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit). | View |
| us-gaap | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses. | View |
| us-gaap | Other Accrued Liabilities, Current | Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. | View |
| us-gaap | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. | View |
| us-gaap | Increase (Decrease) in Accrued Liabilities | The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid. | View |
| us-gaap | Increase (Decrease) in Contract with Customer, Liability | Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable. | View |
| us-gaap | Increase (Decrease) in Deferred Revenue | Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable. | View |
| us-gaap | Increase (Decrease) in Derivative Assets and Liabilities | The increase (decrease) during the period in the net carrying value of derivative instruments reported as assets and liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer). | View |
| us-gaap | Increase (Decrease) in Other Accrued Liabilities | The increase (decrease) during the reporting period in other expenses incurred but not yet paid. | View |
| us-gaap | Increase (Decrease) in Other Operating Assets | Amount of increase (decrease) in operating assets classified as other. | View |
| us-gaap | Increase (Decrease) in Other Operating Liabilities | Amount of increase (decrease) in operating liabilities classified as other. | View |
| us-gaap | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. | View |
| us-gaap | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method. | View |
| us-gaap | Interest Expense | Amount of the cost of borrowed funds accounted for as interest expense. | View |
| us-gaap | Interest Income, Other | Amount of interest income earned from interest bearing assets classified as other. | View |
| us-gaap | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities. | View |
| us-gaap | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. | View |
| us-gaap | Interest Payable, Current | Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). | View |
| us-gaap | Issuance of Stock and Warrants for Services or Claims | Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims. | View |
| us-gaap | Operating Leases, Rent Expense | Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line. | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid | Amount of lessee's undiscounted obligation for lease payment for operating lease. | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year One | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year Five | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year Four | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Year Three | Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year. | View |
| us-gaap | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease. | View |
| us-gaap | Liabilities | Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. | View |
| us-gaap | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. | View |
| us-gaap | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. | View |
| us-gaap | Line of Credit Assumed | The fair value of line of credit assumed in noncash investing or financing activities. | View |
| us-gaap | Line of Credit Facility, Maximum Borrowing Capacity | Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. | View |
| us-gaap | Long-term Debt | Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. | View |
| us-gaap | Long-term Debt, Current Maturities | Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. | View |
| us-gaap | Long-Term Debt, Maturity, Year One | Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Long-Term Debt, Maturity, Year Four | Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Long-Term Debt, Maturity, Year Three | Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Long-Term Debt, Maturity, Year Two | Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). | View |
| us-gaap | Long-Term Debt, Maturity, Remainder of Fiscal Year | Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year. | View |
| us-gaap | Long-term Debt, Excluding Current Maturities | Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations. | View |
| us-gaap | Notes Payable, Noncurrent | Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. | View |
| us-gaap | Marketable Securities | Amount of investment in marketable security. | View |
| us-gaap | Marketable Securities, Current | Amount of investment in marketable security, classified as current. | View |
| us-gaap | Marketable Securities, Gain (Loss) | Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI). | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. | View |
| us-gaap | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | View |
| us-gaap | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | View |
| us-gaap | Net Income (Loss) Available to Common Stockholders, Basic | Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. | View |
| us-gaap | Net Income (Loss) Available to Common Stockholders, Diluted | Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders. | View |
| us-gaap | Notes Payable | Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. | View |
| us-gaap | Notes Payable, Current | Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. | View |
| us-gaap | Number of Reportable Segments | Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements. | View |
| us-gaap | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. | View |
| us-gaap | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. | View |
| us-gaap | Operating Lease, Expense | Amount of operating lease expense. Excludes sublease income. | View |
| us-gaap | Operating Lease, Liability | Present value of lessee's discounted obligation for lease payments from operating lease. | View |
| us-gaap | Operating Lease, Liability, Current | Present value of lessee's discounted obligation for lease payments from operating lease, classified as current. | View |
| us-gaap | Operating Lease, Liability, Noncurrent | Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent. | View |
| us-gaap | Operating Lease, Payments | Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use. | View |
| us-gaap | Operating Lease, Payments, Use | Amount of cash outflow from operating lease to bring another asset to condition and location necessary for its intended use. | View |
| us-gaap | Operating Lease, Right-of-Use Asset | Amount of lessee's right to use underlying asset under operating lease. | View |
| us-gaap | Operating Leases, Future Minimum Payments Due | Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year. | View |
| us-gaap | Operating Leases, Future Minimum Payments Due, Next Twelve Months | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Operating Leases, Future Minimum Payments, Due in Four Years | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Operating Leases, Future Minimum Payments, Due in Three Years | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Operating Leases, Future Minimum Payments, Due in Two Years | Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. | View |
| us-gaap | Operating Lease, Weighted Average Discount Rate, Percent | Weighted average discount rate for operating lease calculated at point in time. | View |
| us-gaap | Other Assets, Noncurrent | Amount of noncurrent assets classified as other. | View |
| us-gaap | Other Expenses | Amount of expense classified as other. | View |
| us-gaap | Other Liabilities, Noncurrent | Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. | View |
| us-gaap | Other Noncash Income (Expense) | Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other. | View |
| us-gaap | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. | View |
| us-gaap | Other Significant Noncash Transaction, Value of Consideration Given | "The value of the noncash (or part noncash) consideration given (for example, liability, equity) in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Other Significant Noncash Transaction, Value of Consideration Received | "The value of the noncash (or part noncash) consideration received in a transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. ""Part noncash"" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period." | View |
| us-gaap | Payments of Financing Costs | The cash outflow for loan and debt issuance costs. | View |
| us-gaap | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. | View |
| us-gaap | Payments to Acquire in Process Research and Development | The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination. | View |
| us-gaap | Payments to Acquire Marketable Securities | Amount of cash outflow for purchase of marketable security. | View |
| us-gaap | Payments to Acquire Property, Plant, and Equipment | The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets. | View |
| us-gaap | Preferred Stock Dividends, Income Statement Impact | The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders. | View |
| us-gaap | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | View |
| us-gaap | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | View |
| us-gaap | Preferred Stock, Shares Issued | Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. | View |
| us-gaap | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | View |
| us-gaap | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. | View |
| us-gaap | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. | View |
| us-gaap | Proceeds from Debt, Net of Issuance Costs | The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. | View |
| us-gaap | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. | View |
| us-gaap | Proceeds from Issuance of Convertible Preferred Stock | The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock. | View |
| us-gaap | Proceeds from Issuance of Preferred Stock and Preference Stock | Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. | View |
| us-gaap | Proceeds from Issuance of Private Placement | The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. | View |
| us-gaap | Proceeds from Issuance of Warrants | The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). | View |
| us-gaap | Proceeds from Notes Payable | The cash inflow from a borrowing supported by a written promise to pay an obligation. | View |
| us-gaap | Proceeds from Sale and Maturity of Marketable Securities | The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period. | View |
| us-gaap | Proceeds from Sale of Debt Securities, Available-for-sale | Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Proceeds from Sale of Property, Plant, and Equipment | The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. | View |
| us-gaap | Proceeds from Warrant Exercises | The cash inflow associated with the amount received from holders exercising their stock warrants. | View |
| us-gaap | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. | View |
| us-gaap | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. | View |
| us-gaap | Repayments of Notes Payable | The cash outflow for a borrowing supported by a written promise to pay an obligation. | View |
| us-gaap | Research and Development Expense (Excluding Acquired in Process Cost) | The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. | View |
| us-gaap | Research and Development in Process | The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition. | View |
| us-gaap | Restricted Cash, Current | Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. | View |
| us-gaap | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s). | View |
| us-gaap | Restructuring Charges | Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. | View |
| us-gaap | Restructuring Costs and Asset Impairment Charges | Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation. | View |
| us-gaap | Retained Earnings (Accumulated Deficit) | The cumulative amount of the reporting entity's undistributed earnings or deficit. | View |
| us-gaap | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. | View |
| us-gaap | Revenues | Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). | View |
| us-gaap | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | Amount of increase in right-of-use asset obtained in exchange for operating lease liability. | View |
| us-gaap | Share-based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | Net number of non-option equity instruments granted to participants. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | Gross number of share options (or share units) granted during the period. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Number of options outstanding, including both vested and non-vested options. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) | Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. | View |
| us-gaap | Share-based Payment Arrangement, Plan Modification, Incremental Cost | An excess of the fair value of the modified award over the fair value of the award immediately before the modification. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Shares to be Repurchased Next Year | An entity expecting to repurchase shares in the following period, generally discloses an estimate of the amount or range of shares to be repurchased. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | Weighted average price at which option holders acquired shares when converting their stock options into shares. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. | View |
| us-gaap | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. | View |
| us-gaap | Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit | The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range. | View |
| us-gaap | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return. | View |
| us-gaap | Stockholders' Equity Note, Stock Split, Conversion Ratio | Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one. | View |
| us-gaap | Stock Issued | The fair value of stock issued in noncash financing activities. | View |
| us-gaap | Stock Issued During Period, Shares, Conversion of Convertible Securities | Number of shares issued during the period as a result of the conversion of convertible securities. | View |
| us-gaap | Stock Issued During Period, Shares, Employee Stock Purchase Plans | Number of shares issued during the period as a result of an employee stock purchase plan. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | View |
| us-gaap | Stock Issued During Period, Value, Conversion of Convertible Securities | The gross value of stock issued during the period upon the conversion of convertible securities. | View |
| us-gaap | Stock Issued During Period, Value, Conversion of Units | Value of stock issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit). | View |
| us-gaap | Stock Issued During Period, Value, Employee Stock Ownership Plan | Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP). | View |
| us-gaap | Stock Issued During Period, Value, Employee Stock Purchase Plan | Aggregate change in value for stock issued during the period as a result of employee stock purchase plan. | View |
| us-gaap | Stock Issued During Period, Value, Issued for Services | Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders. | View |
| us-gaap | Stock Issued During Period, Value, New Issues | Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. | View |
| us-gaap | Stock Issued During Period, Value, Other | Value of shares of stock issued attributable to transactions classified as other. | View |
| us-gaap | Stock Issued During Period, Value, Restricted Stock Award, Gross | Aggregate value of stock related to Restricted Stock Awards issued during the period. | View |
| us-gaap | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). | View |
| us-gaap | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. | View |
| us-gaap | Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) | Tax benefits realized from the exercise of stock options resulting in reductions in the entity's income taxes, which increases net cash provided by operating activities. | View |
| us-gaap | Unrecognized Tax Benefits | Amount of unrecognized tax benefits. | View |
| us-gaap | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns. | View |
| us-gaap | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return. | View |
| us-gaap | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate. | View |
| us-gaap | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic and Diluted | Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). | View |
| us-gaap | Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) | The average number of shares or units issued and outstanding that are used in calculating basic and diluted EPS. | View |
| us-gaap | Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value | Value of outstanding nonredeemable convertible preferred stock or outstanding convertible preferred stock that is redeemable solely at the option of the issuer. | View |
| us-gaap | Deferred Tax Assets, in Process Research and Development | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination. | View |
| us-gaap | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. | View |
| us-gaap | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. | View |
| us-gaap | Investment Banking, Advisory, Brokerage, and Underwriting Fees and Commissions | Amount of fees and commissions from banking, advisory, brokerage, and securities underwriting activities. Activities include, but are not limited to, underwriting securities, private placements of securities, investment advisory and management services, merger and acquisition services, sale and servicing of mutual funds, and other related consulting fees. | View |
| us-gaap | Line of Credit Facility, Remaining Borrowing Capacity | Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding). | View |
| us-gaap | Preferred Stock, Dividend Rate, Percentage | The percentage rate used to calculate dividend payments on preferred stock. | View |
| us-gaap | Redemption Premium | The excess of the (1) fair value of consideration transferred to the holders of a security in excess of (2) the carrying amount of the security reported on the registrant's balance sheet, which will be deducted from net earnings to derive net earnings available to common shareholders. This amount is generally an adjustment considered in the computation of earnings per share. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | Number of options vested. | View |
| us-gaap | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | Weighted average grant-date fair value of options vested. | View |
| us-gaap | Shares, Issued | Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. | View |
| us-gaap | Shares Issued, Price Per Share | Per share or per unit amount of equity securities issued. | View |
| us-gaap | Short-term Investments | Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. | View |
| us-gaap | Accretion (Amortization) of Discounts and Premiums, Investments | The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method. | View |
| us-gaap | Debt Securities, Available-for-sale, Unrealized Gain | Amount of unrealized gain on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Costs and Expenses | Total costs of sales and operating expenses for the period. | View |
| us-gaap | Debt Instrument, Interest Rate, Stated Percentage | Contractual interest rate for funds borrowed, under the debt agreement. | View |
| us-gaap | Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss | Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Debt Securities, Available-for-Sale, Accrued Interest Writeoff | Amount of writeoff of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized by reversing interest income. | View |
| us-gaap | Debt Securities, Available-for-sale, Gain (Loss) | Amount of unrealized and realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). | View |
| us-gaap | Increase (Decrease) in Other Noncurrent Liabilities | Amount of increase (decrease) in noncurrent operating liabilities classified as other. | View |
| us-gaap | Other Long-term Debt | Amount of long-term debt classified as other. | View |
| us-gaap | Proceeds from Sale, Maturity and Collection of Short-term Investments | The cash inflow from sales, maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term. | View |
| us-gaap | Unrealized Gain (Loss) on Investments | Amount of unrealized gain (loss) on investment. | View |
| us-gaap | Operating Lease, Lease Income, Lease Payments | Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable. | View |
| us-gaap | Other Nonoperating Gains (Losses) | Amount of gain (loss) related to nonoperating activities, classified as other. | View |
| us-gaap | Stock Issued During Period, Shares, Other | Number of shares of stock issued attributable to transactions classified as other. | View |
| us-gaap | Deposits Assets, Current | Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter. | View |
| us-gaap | Other Long-term Debt, Current | Amount of long-term debt classified as other, payable within one year or the operating cycle, if longer. | View |
| us-gaap | Other Prepaid Expense, Current | Amount of asset related to consideration paid in advance for other costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Prepaid Expense, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Prepaid Expense | Carrying amount as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs. | View |
| us-gaap | Prepaid Insurance | Amount of asset related to consideration paid in advance for insurance that provides economic benefits within a future period of one year or the normal operating cycle, if longer. | View |
| us-gaap | Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid | Amount of payment greater than the preceding installment payments to be paid at final maturity date of debt. | View |
| us-gaap | Interest and Other Income | The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business). | View |
| us-gaap | Equity Method Investment, Quoted Market Value | This item represents the aggregate value of each identified investment accounted for under the equity method of accounting based on the quoted market price for those investments in common stock for which a quoted market price is available. | View |
| us-gaap | Debt, Current | Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer. | View |
| us-gaap | Other Research and Development Expense | Amount of other research and development expense. | View |
| us-gaap | Proceeds from (Repayments of) Debt | The net cash inflow or outflow in aggregate debt due to repayments and proceeds from additional borrowings. | View |
| us-gaap | Realized Investment Gains (Losses) | Amount of realized gain (loss) on investment. | View |
| us-gaap | Lease, Cost | Amount of lease cost recognized by lessee for lease contract. | View |
| us-gaap | Operating Lease, Cost | Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability. | View |
| us-gaap | Postemployment Benefits, Period Expense | Period expense related to postemployment benefits. | View |
| us-gaap | Short-term Lease, Cost | Amount of short-term lease cost, excluding expense for lease with term of one month or less. | View |
Chart of Accounts => Accounts
| Name | View |
|---|---|
| Accrued Professional Fees, Current | View |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | View |
| Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss), Net of Tax (Deprecated 2018-01-31) | View |
| Common Stock, Capital Shares Reserved for Future Issuance | View |
| Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | View |
| Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | View |
| Debt Securities, Available-for-sale, Realized Gain (Loss) | View |
| Debt Securities, Available-for-sale, Unrealized Gain (Loss) | View |
| Deferred Tax Liabilities, Gross | View |
| Gain (Loss) on Disposition of Property Plant Equipment | View |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | View |
| Increase (Decrease) in Accounts Payable | View |
| Net Income (Loss) Available to Common Stockholders, Diluted | View |
| Notes Payable, Current | View |
| Other Liabilities, Noncurrent | View |
| Share-based Payment Arrangement, Noncash Expense | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | View |
| Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit | View |
| Stockholders' Equity Attributable to Parent | View |
| Debt Instrument, Periodic Payment Terms, Balloon Payment to be Paid | View |
| Prepaid Expense | View |
| Prepaid Insurance | View |
| Accrued Payroll Taxes, Current | View |
| Financing Interest Expense | View |
| Deposits Assets, Current | View |
| Other Long-term Debt, Current | View |
| Other Prepaid Expense, Current | View |
| Accrued Liabilities, Current | View |
| Accounts Payable, Current | View |
| Accretion Expense | View |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | View |
| Additional Paid in Capital | View |
| Additional Paid in Capital, Common Stock | View |
| Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt | View |
| Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock | View |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | View |
| Adjustments to Additional Paid in Capital, Stock Split | View |
| Adjustments to Additional Paid in Capital, Warrant Issued | View |
| Share-based Payment Arrangement, Expense | View |
| Amortization of Debt Issuance Costs and Discounts | View |
| Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | View |
| Assets | View |
| Assets, Current | View |
| Assets, Fair Value Disclosure | View |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | View |
| Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | View |
| Debt Securities, Available-for-sale, Amortized Cost | View |
| Available-for-sale Securities | View |
| Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | View |
| Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | View |
| Available-for-sale Securities, Amortized Cost Basis | View |
| Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | View |
| Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | View |
| Debt Securities, Available-for-sale | View |
| Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) | View |
| Available-for-sale Securities, Gross Realized Gain (Loss) | View |
| Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) | View |
| Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Aggregate Losses (Deprecated 2013-01-31) | View |
| Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) | View |
| Business Acquisition, Transaction Costs | View |
| Business Acquisition, Percentage of Voting Interests Acquired | View |
| Business Acquisition, Share Price | View |
| Business Combination, Consideration Transferred, Including Equity Interest in Acquiree Held Prior to Combination | View |
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets | View |
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents | View |
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets | View |
| Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net | View |
| Capital Expenditures Incurred but Not yet Paid | View |
| Cash Acquired from Acquisition | View |
| Cash and Cash Equivalents, at Carrying Value | View |
| Cash and Cash Equivalents, Fair Value Disclosure | View |
| Cash and Cash Equivalents, Period Increase (Decrease) | View |
| Cash, Cash Equivalents, and Short-term Investments | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | View |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | View |
| Cash Equivalents, at Carrying Value | View |
| Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) | View |
| Class of Warrant or Right, Exercise Price of Warrants or Rights | View |
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights | View |
| Class of Warrant or Right, Outstanding | View |
| Prepaid Expense, Current | View |
| Common Stock, Par or Stated Value Per Share | View |
| Common Stock, Shares Authorized | View |
| Common Stock, Shares, Issued | View |
| Common Stock, Shares, Outstanding | View |
| Common Stock, Value, Subscriptions | View |
| Common Stock, Value, Issued | View |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | View |
| Conversion of Stock, Amount Converted | View |
| Convertible Preferred Stock, Shares Issued upon Conversion | View |
| Long-term Debt, Gross | View |
| Debt Instrument, Convertible, Beneficial Conversion Feature | View |
| Debt Instrument, Unamortized Discount | View |
| Deferred Rent Credit, Noncurrent | View |
| Deferred Revenue, Current | View |
| Deferred Revenue, Noncurrent | View |
| Deferred Revenue, Revenue Recognized (Deprecated 2016-01-31) | View |
| Deferred Revenue, Revenue Recognized | View |
| Deferred Tax Assets, Deferred Income | View |
| Deferred Tax Assets, Gross | View |
| Deferred Tax Assets, Net | View |
| Deferred Tax Assets, Net of Valuation Allowance | View |
| Deferred Tax Assets, Operating Loss Carryforwards | View |
| Deferred Tax Assets, Other | View |
| Deferred Tax Assets, Property, Plant and Equipment | View |
| Deferred Tax Assets, Tax Credit Carryforwards, Research | View |
| Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | View |
| Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | View |
| Deferred Tax Assets, Valuation Allowance | View |
| Deferred Tax Expense from Stock Options Exercised | View |
| Depreciation | View |
| Depreciation, Amortization and Accretion, Net | View |
| Depreciation, Depletion and Amortization | View |
| Derivative Liability, Fair Value, Gross Liability | View |
| Derivative Liability, Current | View |
| Dividend, Share-based Payment Arrangement, Cash | View |
| Earnings Per Share, Basic | View |
| Earnings Per Share, Basic and Diluted | View |
| Earnings Per Share, Diluted | View |
| Effective Income Tax Rate Reconciliation, Percent | View |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | View |
| Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | View |
| Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | View |
| Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | View |
| Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | View |
| Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | View |
| Employee-related Liabilities, Current | View |
| Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | View |
| Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | View |
| Fair Value Adjustment of Warrants | View |
| Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) | View |
| Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) | View |
| Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) | View |
| Long-term Federal Home Loan Bank Advances | View |
| Gain (Loss) on Extinguishment of Debt | View |
| General and Administrative Expense | View |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | View |
| Income (Loss) from Continuing Operations before Income Taxes, Foreign | View |
| Income (Loss) from Continuing Operations, Per Basic and Diluted Share | View |
| Income Tax Expense (Benefit) | View |
| Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | View |
| Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | View |
| Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | View |
| Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount | View |
| Increase (Decrease) in Accounts Receivable | View |
| Increase (Decrease) in Accrued Liabilities | View |
| Increase (Decrease) in Contract with Customer, Liability | View |
| Increase (Decrease) in Deferred Revenue | View |
| Increase (Decrease) in Derivative Assets and Liabilities | View |
| Increase (Decrease) in Employee Related Liabilities | View |
| Increase (Decrease) in Other Accrued Liabilities | View |
| Increase (Decrease) in Other Operating Assets | View |
| Increase (Decrease) in Other Operating Liabilities | View |
| Increase (Decrease) in Prepaid Expense and Other Assets | View |
| Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | View |
| Interest Expense | View |
| Interest Income, Other | View |
| Interest Paid, Including Capitalized Interest, Operating and Investing Activities | View |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | View |
| Interest Payable, Current | View |
| Issuance of Stock and Warrants for Services or Claims | View |
| Operating Leases, Rent Expense | View |
| Lessee, Operating Lease, Liability, to be Paid | View |
| Lessee, Operating Lease, Liability, to be Paid, Year One | View |
| Lessee, Operating Lease, Liability, to be Paid, Year Five | View |
| Lessee, Operating Lease, Liability, to be Paid, Year Four | View |
| Lessee, Operating Lease, Liability, to be Paid, Year Three | View |
| Lessee, Operating Lease, Liability, to be Paid, Year Two | View |
| Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | View |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount | View |
| Liabilities | View |
| Liabilities and Equity | View |
| Liabilities, Current | View |
| Line of Credit Assumed | View |
| Line of Credit Facility, Maximum Borrowing Capacity | View |
| Long-term Debt | View |
| Long-term Debt, Current Maturities | View |
| Long-Term Debt, Maturity, Year One | View |
| Long-Term Debt, Maturity, Year Four | View |
| Long-Term Debt, Maturity, Year Three | View |
| Long-Term Debt, Maturity, Year Two | View |
| Long-Term Debt, Maturity, Remainder of Fiscal Year | View |
| Long-term Debt, Excluding Current Maturities | View |
| Notes Payable, Noncurrent | View |
| Marketable Securities | View |
| Marketable Securities, Current | View |
| Marketable Securities, Gain (Loss) | View |
| Net Cash Provided by (Used in) Financing Activities | View |
| Net Cash Provided by (Used in) Financing Activities, Continuing Operations | View |
| Net Cash Provided by (Used in) Investing Activities | View |
| Net Cash Provided by (Used in) Investing Activities, Continuing Operations | View |
| Net Cash Provided by (Used in) Operating Activities | View |
| Net Cash Provided by (Used in) Operating Activities, Continuing Operations | View |
| Net Income (Loss) Attributable to Parent | View |
| Net Income (Loss) Available to Common Stockholders, Basic | View |
| Notes Payable | View |
| Number of Reportable Segments | View |
| Operating Expenses | View |
| Operating Income (Loss) | View |
| Operating Lease, Expense | View |
| Operating Lease, Liability | View |
| Operating Lease, Liability, Current | View |
| Operating Lease, Liability, Noncurrent | View |
| Operating Lease, Payments | View |
| Operating Lease, Payments, Use | View |
| Operating Lease, Right-of-Use Asset | View |
| Operating Leases, Future Minimum Payments Due | View |
| Operating Leases, Future Minimum Payments Due, Next Twelve Months | View |
| Operating Leases, Future Minimum Payments, Due in Four Years | View |
| Operating Leases, Future Minimum Payments, Due in Three Years | View |
| Operating Leases, Future Minimum Payments, Due in Two Years | View |
| Operating Lease, Weighted Average Discount Rate, Percent | View |
| Other Accrued Liabilities, Current | View |
| Other Accrued Liabilities, Noncurrent | View |
| Other Assets, Noncurrent | View |
| OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | View |
| Other Expenses | View |
| Other Noncash Income (Expense) | View |
| Other Nonoperating Income (Expense) | View |
| Other Significant Noncash Transaction, Value of Consideration Given | View |
| Other Significant Noncash Transaction, Value of Consideration Received | View |
| Payments of Financing Costs | View |
| Payments of Stock Issuance Costs | View |
| Payments to Acquire in Process Research and Development | View |
| Payments to Acquire Marketable Securities | View |
| Payments to Acquire Property, Plant, and Equipment | View |
| Preferred Stock Dividends, Income Statement Impact | View |
| Preferred Stock, Par or Stated Value Per Share | View |
| Preferred Stock, Shares Authorized | View |
| Preferred Stock, Shares Issued | View |
| Preferred Stock, Shares Outstanding | View |
| Preferred Stock, Value, Issued | View |
| Prepaid Expense and Other Assets, Current | View |
| Proceeds from Debt, Net of Issuance Costs | View |
| Proceeds from Issuance of Common Stock | View |
| Proceeds from Issuance of Convertible Preferred Stock | View |
| Proceeds from Issuance of Preferred Stock and Preference Stock | View |
| Proceeds from Issuance of Private Placement | View |
| Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | View |
| Proceeds from Issuance of Warrants | View |
| Proceeds from Notes Payable | View |
| Proceeds from Sale and Maturity of Marketable Securities | View |
| Proceeds from Sale of Debt Securities, Available-for-sale | View |
| Proceeds from Sale of Property, Plant, and Equipment | View |
| Proceeds from Warrant Exercises | View |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | View |
| Property, Plant and Equipment, Net | View |
| Repayments of Notes Payable | View |
| Research and Development Expense | View |
| Research and Development Expense (Excluding Acquired in Process Cost) | View |
| Research and Development in Process | View |
| Restricted Cash, Current | View |
| Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | View |
| Restructuring Charges | View |
| Restructuring Costs and Asset Impairment Charges | View |
| Retained Earnings (Accumulated Deficit) | View |
| Revenue from Contract with Customer, Excluding Assessed Tax | View |
| Revenues | View |
| Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | View |
| Severance Costs | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value (Deprecated 2013-01-31) | View |
| Share-based Payment Arrangement, Plan Modification, Incremental Cost | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Shares to be Repurchased Next Year | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | View |
| Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | View |
| Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit | View |
| Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit | View |
| Share-based Goods and Nonemployee Services Transaction, Expense (Deprecated 2013-01-31) | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | View |
| Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price | View |
| Stockholders' Equity Note, Stock Split, Conversion Ratio | View |
| Stock Issued | View |
| Stock Issued During Period, Shares, Conversion of Convertible Securities | View |
| Stock Issued During Period, Shares, Employee Stock Purchase Plans | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | View |
| Stock Issued During Period, Value, Conversion of Convertible Securities | View |
| Stock Issued During Period, Value, Conversion of Units | View |
| Stock Issued During Period, Value, Employee Stock Ownership Plan | View |
| Stock Issued During Period, Value, Employee Stock Purchase Plan | View |
| Stock Issued During Period, Value, Issued for Services | View |
| Stock Issued During Period, Value, New Issues | View |
| Stock Issued During Period, Value, Other | View |
| Stock Issued During Period, Value, Restricted Stock Award, Gross | View |
| Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | View |
| Stock Issued During Period, Value, Stock Options Exercised | View |
| Tax Benefit from Stock Options Exercised (Deprecated 2013-01-31) | View |
| Unrecognized Tax Benefits | View |
| Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | View |
| Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | View |
| Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | View |
| Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | View |
| Unrecognized Tax Benefits that Would Impact Effective Tax Rate | View |
| Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | View |
| Weighted Average Number of Shares Outstanding, Diluted | View |
| Weighted Average Number of Shares Outstanding, Basic and Diluted | View |
| Weighted Average Number of Shares Outstanding, Basic | View |
| Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) | View |
| Convertible Preferred Stock, Nonredeemable or Redeemable, Issuer Option, Value | View |
| Deferred Tax Assets, in Process Research and Development | View |
| Deferred Tax Assets, Operating Loss Carryforwards, State and Local | View |
| Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | View |
| Investment Banking, Advisory, Brokerage, and Underwriting Fees and Commissions | View |
| Line of Credit Facility, Remaining Borrowing Capacity | View |
| Preferred Stock, Dividend Rate, Percentage | View |
| Redemption Premium | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | View |
| Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | View |
| Shares, Issued | View |
| Shares Issued, Price Per Share | View |
| Short-term Investments | View |
| Accretion (Amortization) of Discounts and Premiums, Investments | View |
| Debt Securities, Available-for-sale, Unrealized Gain | View |
| Debt Securities, Available-for-sale, Unrealized Loss | View |
| Costs and Expenses | View |
| Debt Instrument, Interest Rate, Stated Percentage | View |
| Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss | View |
| Debt Securities, Available-for-Sale, Accrued Interest Writeoff | View |
| Debt Securities, Available-for-sale, Gain (Loss) | View |
| Increase (Decrease) in Other Noncurrent Liabilities | View |
| Other Long-term Debt | View |
| Payments to Acquire Short-term Investments | View |
| Proceeds from Sale, Maturity and Collection of Short-term Investments | View |
| Unrealized Gain (Loss) on Investments | View |
| Operating Lease, Lease Income, Lease Payments | View |
| Other Nonoperating Gains (Losses) | View |
| Stock Issued During Period, Shares, Other | View |
| Interest and Other Income | View |
| Equity Method Investment, Quoted Market Value | View |
| Debt, Current | View |
| Other Research and Development Expense | View |
| Proceeds from (Repayments of) Debt | View |
| Realized Investment Gains (Losses) | View |
| Repayments of Long-term Lines of Credit | View |
| Lease, Cost | View |
| Operating Lease, Cost | View |
| Postemployment Benefits, Period Expense | View |
| Short-term Lease, Cost | View |